Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?

Basit Öğe Kaydı
dc.authorid0000-0003-0230-6575
dc.authorid0000-0001-5825-8627
dc.authorid0000-0002-4951-6716
dc.contributor.authorİbişoğlu, Ersin
dc.contributor.authorÇakal, Sinem
dc.contributor.authorÇakal, Beytullah
dc.contributor.authorGüneş, Hacı Murat
dc.contributor.authorBoyraz, Bedrettin
dc.contributor.authorBoztosun, Bilal
dc.date.accessioned2021-12-16T08:27:00Z
dc.date.available2021-12-16T08:27:00Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı
dc.description.abstractObjective: The data on using novolimus-eluting DESolve bioresorbable scaffolds (BVS) for long-segment coronary artery lesions remains insufficient. In this study, our main objective was to assess the long-term effects of the overlapping applications of both DESolve-DESolve and the drug-eluting stent (DES)-DESolve. Methods: A single-centered study of 103 patients scheduled for DESolve placement for long-segment lesions (>28 mm) was conducted (October 2013 to November 2016). A DESolve-DESolve overlap was used on 43 patients and a DES-DESolve overlap on 60 patients. Acute procedural success and major adverse cardiac events (MACE) (stent thrombosis, targeted vessel revascularization, targeted lesion revascularization, and cardiac death) were evaluated. The patients were followed up for 48 months. Results: Revascularization was performed on 4 (6.7%) patients in the DES-DESolve group and 5 (11.6%) patients in the DESolve-DESolve group for target lesion revascularization. Among the study population, 10 (9.7%) patients had MACE, including 5 (8.3%) patients in the DES-DESolve group and 5 (11.6%) patients in the DESolve-DESolve group. Conclusion: The positive results of our study concerning the use of DESolve for the treatment of long coronary lesions demonstrate that BVS will emerge with new platforms and become non-inferior to the DES.
dc.identifier.citationİbişoğlu, E., Çakal, S., Çakal, B., Güneş, H. M., Boyraz, B. ve Boztosun, B. (2021). Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic? Anatolian Journal of Cardiology, 25(12), 912-919. https://dx.doi.org/10.5152/AnatolJCardiol.2021.25
dc.identifier.doi10.5152/AnatolJCardiol.2021.25
dc.identifier.endpage919
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue12
dc.identifier.scopusqualityQ3
dc.identifier.startpage912
dc.identifier.trdizinid488138
dc.identifier.urihttps://dx.doi.org/10.5152/AnatolJCardiol.2021.25
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8683
dc.identifier.volume25
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTurkish Society of Cardiology
dc.relation.ispartofAnatolian Journal of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBioresorbable Vascular Scaffold
dc.subjectDESolve
dc.subjectOverlapping
dc.subjectHybrid Strategy
dc.titleLong-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Cakal-Beytullah-2021.pdf
Boyut:
562.35 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu